|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/282 | |
| A61K 31/337 | |||
| A61K 31/4745 | |||
| A61K 31/513 | |||
| A61K 31/519 | |||
| A61K 31/704 | |||
| A61K 31/7068 | |||
| A61K 33/24 | |||
| A61K 45/06 | |||
| A61K 31/4412 | |||
| A61K 31/4965 | |||
| A61K 31/506 |
| (11) | Number of the document | 2435041 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10723967.5 |
| Date of filing the European patent application | 2010-05-21 | |
| (97) | Date of publication of the European application | 2012-04-04 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/057027 |
| Date | 2010-05-21 |
| (87) | Number | WO 2010/136394 |
| Date | 2010-12-02 |
| (30) | Number | Date | Country code |
| 09161111 | 2009-05-26 | EP |
| (72) |
VALSASINA, Barbara, IT
BERIA, Italo, IT
CIAVOLELLA, Antonella, IT
BALLINARI, Dario, IT
PESENTI, Enrico, IT
MOLL, Juergen, IT
|
| (73) |
Nerviano Medical Sciences S.r.l.,
11 Viale Pasteur, 10 P.O. Box 11, 20014 Nerviano (MI),
IT
|
| (54) | Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent |
| Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent |